PHLORA Labs

Ending the cycle of recurrent vaginal infections

The Challenge

Recurrent vaginal infections affect 289 million women worldwide, costing billions in treatment and lost productivity, and far more in mental toll and lost confidence. Conventional products clear each single episode, but deplete the protective environment, so the infection returns. Women are trapped in a cycle of treatment, relief and relapse.

The Opportunity

PHLORA Labs is developing a brand of products designed for maintenance – not another single-episode fix. Our novel formulation restores and helps maintain the naturally acidic vaginal environment, forming the protective mechanism against infections. Made in various forms for easy, regular use, so women can choose what fits their body, their routine and their culture.

The team

Sophia Mok

Co-Founder & CTO

Alina Agipa

Co-Founder

Gianni Austin

Co-Founder & CSO

The Venture

Traction

WE Innovate 2026 Semi-finalists + winner of Lauren Dennis award

VCC 2026 Health & Wellbeing Track

UKRI ICURe Engage + Discover (starting)

100+ purchase interests.
15 expert endorsements.

Strong advisory board of clinicians, researchers, founders, community leads.

50+ primary customer interviews.
Patient interaction with PERC.

Prototyping @ Imperial Hackspace.
IP landscape mapped with lawyer.
Regulatory pathway under discussion w/ MHRA

PHLORA Labs

The Challenge

The Opportunity

Socials

The team

Stage

Programme

Industry / Sector

Cohort

The Venture

Traction

Can you help PHLORA Labs grow?

Venture Showcase